Thao Ho

Renowned for innovative contributions in the field of neonatal care and molecular medicine, Dr. Thao Ho is an esteemed Associate Professor of Molecular Medicine, Pediatrics, and Nursing at the University of South Florida. Since joining USF in 2016, Dr. Ho has been a pivotal figure in the Neonatology Division of the Pediatrics Department, where her expertise as a neonatologist has significantly advanced the understanding and treatment of neonatal conditions. Dr. Ho's research is primarily focused on the intricate relationship between anemia, oral iron supplementation, and the intestinal microbiome, particularly in Very Low Birth Weight (VLBW) infants. Her work delves into the complex mechanisms of inflammation and the barriers that affect the health outcomes of these vulnerable infants. By exploring these critical areas, Dr. Ho aims to develop and refine clinical management strategies that optimize anemia treatment and iron supplementation, ultimately improving the quality of care for VLBW infants. Her dedication to research is matched by her commitment to education, where she actively mentors students and collaborates with colleagues to foster a dynamic learning environment. Dr. Ho's interdisciplinary approach bridges the gap between molecular medicine and practical clinical applications, making her a respected leader in her field. Dr. Ho's contributions extend beyond her research and teaching roles, as she actively participates in various professional organizations and conferences, sharing her insights and findings with the broader medical community. Her work not only enhances the understanding of neonatal health but also paves the way for future innovations in pediatric care. Through her ongoing research and dedication to improving neonatal outcomes, Dr. Thao Ho continues to make significant strides in the field of neonatology, earning her a reputation as a leading expert in her areas of interest. Her efforts are instrumental in shaping the future of neonatal care and ensuring better health outcomes for the youngest and most vulnerable patients.